IL Receptor

IL Receptor製品

  • All (7)
  • IL Receptor阻害剤 (3)
  • IL Receptor抗体(2)
  • IL Receptorモジュレータ(2)
  • 新製品
製品コード 製品名称 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S1322 Dexamethasone Dexamethasone is a potent synthetic member of the glucocorticoid class of steroid drugs, and an interleukin receptor modulator that has anti-inflammatory and immunosuppressant effects. Dexamethasone induces autophagy and mitophagy. Dexamethasone is tested in hospitalized patients with COVID-19 and is found to have benefits for critically ill patients.
Cell Host Microbe, 2024, S1931-3128(24)00005-2
Nat Commun, 2024, 15(1):1176
Oncogene, 2024, 43(4):235-247
A2012 Tocilizumab (anti-IL-6R) Tocilizumab is a humanized monoclonal antibody that binds to the interleukin-6 receptor, MW: 148 KD.
Nature, 2023, 615(7951):305-314
Nat Commun, 2023, 14(1):6959
Front Cell Dev Biol, 2023, 11:1244120
S3124 Dexamethasone Acetate Dexamethasone (NSC 39471,Dexamethasone 21-acetate) is a potent synthetic member of the glucocorticoid class of steroid drugs, and an interleukin receptor modulator that has anti-inflammatory and immunosuppressant effects.
STAR Protoc, 2023, 4(2):102342
Exp Mol Med, 2022, 54(9):1450-1460
iScience, 2022, 25(12):105682
S4028 Dexamethasone Sodium Phosphate Dexamethasone (Dexamethasone 21-phosphate disodium salt) is a potent synthetic member of the glucocorticoid class of steroid drugs, and an interleukin receptor modulator that has anti-inflammatory and immunosuppressant effects.
Pharmaceutics, 2022, 14(2)400
Front Oncol, 2022, 12:888695
Sci Rep, 2022, 12(1):10616
A2011 Sarilumab (anti-IL-6Rα) Sarilumab is a fully human anti-IL-6Rα mAb that binds membrane-bound and soluble human IL-6Rα with high affinity, MW: 144.13 KD.
Biomed Pharmacother, 2024, 173:116357
Small, 2023, e2203725.
Cancer Lett, 2022, 524:161-171
S8562 IRAK4-IN-2 IRAK4-IN-2 is a reversible kinase inhibitor that modulates IRAK4 function in both the toll-like receptor (TLR) and interleukin 1 receptor (IL-1R) signaling cascades.
Cancer Lett, 2021, 503:75-90
Cancer Lett, 2021, 503:75-90
S5764 YM 90709 YM 90709 is a novel IL-5 inhibitor which selectively blocks the binding of IL-5 to the IL-5 receptor (IL-5R).
S4028 Dexamethasone Sodium Phosphate Dexamethasone (Dexamethasone 21-phosphate disodium salt) is a potent synthetic member of the glucocorticoid class of steroid drugs, and an interleukin receptor modulator that has anti-inflammatory and immunosuppressant effects.
Pharmaceutics, 2022, 14(2)400
Front Oncol, 2022, 12:888695
Sci Rep, 2022, 12(1):10616
S8562 IRAK4-IN-2 IRAK4-IN-2 is a reversible kinase inhibitor that modulates IRAK4 function in both the toll-like receptor (TLR) and interleukin 1 receptor (IL-1R) signaling cascades.
Cancer Lett, 2021, 503:75-90
Cancer Lett, 2021, 503:75-90
S5764 YM 90709 YM 90709 is a novel IL-5 inhibitor which selectively blocks the binding of IL-5 to the IL-5 receptor (IL-5R).
A2012 Tocilizumab (anti-IL-6R) Tocilizumab is a humanized monoclonal antibody that binds to the interleukin-6 receptor, MW: 148 KD.
Nature, 2023, 615(7951):305-314
Nat Commun, 2023, 14(1):6959
Front Cell Dev Biol, 2023, 11:1244120
A2011 Sarilumab (anti-IL-6Rα) Sarilumab is a fully human anti-IL-6Rα mAb that binds membrane-bound and soluble human IL-6Rα with high affinity, MW: 144.13 KD.
Biomed Pharmacother, 2024, 173:116357
Small, 2023, e2203725.
Cancer Lett, 2022, 524:161-171
S1322 Dexamethasone Dexamethasone is a potent synthetic member of the glucocorticoid class of steroid drugs, and an interleukin receptor modulator that has anti-inflammatory and immunosuppressant effects. Dexamethasone induces autophagy and mitophagy. Dexamethasone is tested in hospitalized patients with COVID-19 and is found to have benefits for critically ill patients.
Cell Host Microbe, 2024, S1931-3128(24)00005-2
Nat Commun, 2024, 15(1):1176
Oncogene, 2024, 43(4):235-247
S3124 Dexamethasone Acetate Dexamethasone (NSC 39471,Dexamethasone 21-acetate) is a potent synthetic member of the glucocorticoid class of steroid drugs, and an interleukin receptor modulator that has anti-inflammatory and immunosuppressant effects.
STAR Protoc, 2023, 4(2):102342
Exp Mol Med, 2022, 54(9):1450-1460
iScience, 2022, 25(12):105682

IL Receptor阻害剤の選択性比較

Tags: IL Receptor inhibitor|IL Receptor agonist|IL Receptor activator|IL Receptor inducer|IL Receptor antagonist|IL Receptor signaling pathway|IL Receptor assay kit